Publication: 4744

Publication: 4744

Association of inflammation-associated patient-reported outcomes (PROs) and BMI with clinical outcomes: a pre-specified secondary analysis from an adjuvant aspirin vs. placebo after breast cancer trial (Alliance A011502)

Google Scholar

Citation:

Year:: 2026
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 4279 4280 4427
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882; UG1CA189961, UG1CA233180, UG1CA233196, UG1CA233247, UG1CA233337, UG1CA233373; U10CA180820 (ECOG-ACRIN), U10CA180868 (NRG Oncology), U10CA180888 (SWOG), R03TR004607-01 (SG), K08CA279766-01A1

Corr. Author:
Authors:: Shipra Gandhi Karla V. Ballman Sarah K Reed Michelle D. Holmes Kala Visvanathan Banu Symington Anna Weiss Amylou C. Dueck Eric P. Winer Lisa A. Carey Ann H. Partridge Wendy Y. Chen

Networks:: GA005, LAPS-CT018, LAPS-MA036, LAPS-MD017, LAPS-MN026, NC007, NY167, PCRC

Study: Alliance-A011502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: